✦ LIBER ✦

Safety and Efficacy of Adjuvant Glycoprotein IIb/IIIa Inhibitors During Primary Percutaneous Coronary Intervention Performed From the Radial Approach for Acute ST Segment Elevation Myocardial Infarction

✍ Scribed by Iqbal, Zafar; Cohen, Marc; Pollack, Charles; Goldstein, Patrick; Zeymer, Uwe; Huber, Kurt; Barthelemy, Olivier; Cayla, Guillaume; Aout, Mounir; Vicaut, Eric; Montalescot, Gilles

Book ID: 122743352
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 396 KB
Volume: 111
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2013.02.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early vs. late administration of glycopr

Early vs. late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction. A meta-analysis

✍ G. Montalescot; M. Borentain; L. Payot; J.P. Collet; D. Thomas 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 38 KB

The Benefits of Platelet Glycoprotein II

The Benefits of Platelet Glycoprotein IIb/IIIa Receptor Inhibition During Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: Drug-Specific or Class Effect?

✍ Sorin J. Brener 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 142 KB

UPSTREAM VERSUS DEFERRED ADMINISTRATION

UPSTREAM VERSUS DEFERRED ADMINISTRATION OF SMALL-MOLECULE GLYCOPROTEIN IIB/IIIA INHIBITORS IN PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM RANDOMIZED CLINICAL TRIALS

✍ Lili Dong; Feng Zhang; Xianhong Shu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Timing of Glycoprotein IIb/IIIa Inhibito

Timing of Glycoprotein IIb/IIIa Inhibitor Use and Outcomes Among Patients With Non–ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention (Results from CRUSADE)

✍ Pierluigi Tricoci; Eric D. Peterson; Anita Y. Chen; L. Kristin Newby; Robert A. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 164 KB

DO WE STILL NEED A GLYCOPROTEIN IIB/IIIA

DO WE STILL NEED A GLYCOPROTEIN IIB/IIIA INHIBITOR FOR ACUTE ST-SEGMENT-ELEVATION MYOCARDIAL INFARCTION IN PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION AND PRETREATED WITH A LOADING DOSE OF CLOPIDOGREL?

✍ Lili Dong; Yongshi Wang; Xianhong Shu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 239 KB

The safety and efficacy of enoxaparin as

The safety and efficacy of enoxaparin as antithrombin therapy during primary percutaneous coronary intervention for ST-elevation myocardial infarction

✍ H.M. Medina; B.Y.C. Cheong; L. O'Meallie; J.J. Ferguson; J.G. Díez 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 66 KB